300 related articles for article (PubMed ID: 25109336)
1. GD3 synthase regulates epithelial-mesenchymal transition and metastasis in breast cancer.
Sarkar TR; Battula VL; Werden SJ; Vijay GV; Ramirez-Peña EQ; Taube JH; Chang JT; Miura N; Porter W; Sphyris N; Andreeff M; Mani SA
Oncogene; 2015 Jun; 34(23):2958-67. PubMed ID: 25109336
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of serine 367 of FOXC2 by p38 regulates ZEB1 and breast cancer metastasis, without impacting primary tumor growth.
Werden SJ; Sphyris N; Sarkar TR; Paranjape AN; LaBaff AM; Taube JH; Hollier BG; Ramirez-Peña EQ; Soundararajan R; den Hollander P; Powell E; Echeverria GV; Miura N; Chang JT; Piwnica-Worms H; Rosen JM; Mani SA
Oncogene; 2016 Nov; 35(46):5977-5988. PubMed ID: 27292262
[TBL] [Abstract][Full Text] [Related]
3. Disialyl GD2 ganglioside suppresses ICAM-1-mediated invasiveness in human breast cancer MDA-MB231 cells.
Kwon KM; Chung TW; Kwak CH; Choi HJ; Kim KW; Ha SH; Cho SH; Lee YC; Ha KT; Lee MJ; Kim CH
Int J Biol Sci; 2017; 13(3):265-275. PubMed ID: 28367091
[TBL] [Abstract][Full Text] [Related]
4. Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis.
Battula VL; Shi Y; Evans KW; Wang RY; Spaeth EL; Jacamo RO; Guerra R; Sahin AA; Marini FC; Hortobagyi G; Mani SA; Andreeff M
J Clin Invest; 2012 Jun; 122(6):2066-78. PubMed ID: 22585577
[TBL] [Abstract][Full Text] [Related]
5. Interaction of glycosphingolipids GD3 and GD2 with growth factor receptors maintains breast cancer stem cell phenotype.
Liang YJ; Wang CY; Wang IA; Chen YW; Li LT; Lin CY; Ho MY; Chou TL; Wang YH; Chiou SP; Lin YJ; Yu J
Oncotarget; 2017 Jul; 8(29):47454-47473. PubMed ID: 28537895
[TBL] [Abstract][Full Text] [Related]
6. Triptolide suppresses the growth and metastasis of non-small cell lung cancer by inhibiting β-catenin-mediated epithelial-mesenchymal transition.
Deng QD; Lei XP; Zhong YH; Chen MS; Ke YY; Li Z; Chen J; Huang LJ; Zhang Y; Liang L; Lin ZX; Liu Q; Li SP; Yu XY
Acta Pharmacol Sin; 2021 Sep; 42(9):1486-1497. PubMed ID: 33893396
[TBL] [Abstract][Full Text] [Related]
7. The ganglioside G(D2) induces the constitutive activation of c-Met in MDA-MB-231 breast cancer cells expressing the G(D3) synthase.
Cazet A; Bobowski M; Rombouts Y; Lefebvre J; Steenackers A; Popa I; Guérardel Y; Le Bourhis X; Tulasne D; Delannoy P
Glycobiology; 2012 Jun; 22(6):806-16. PubMed ID: 22301273
[TBL] [Abstract][Full Text] [Related]
8. IKK inhibition by BMS-345541 suppresses breast tumorigenesis and metastases by targeting GD2+ cancer stem cells.
Battula VL; Nguyen K; Sun J; Pitner MK; Yuan B; Bartholomeusz C; Hail N; Andreeff M
Oncotarget; 2017 Jun; 8(23):36936-36949. PubMed ID: 28415808
[TBL] [Abstract][Full Text] [Related]
9. FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer.
Hollier BG; Tinnirello AA; Werden SJ; Evans KW; Taube JH; Sarkar TR; Sphyris N; Shariati M; Kumar SV; Battula VL; Herschkowitz JI; Guerra R; Chang JT; Miura N; Rosen JM; Mani SA
Cancer Res; 2013 Mar; 73(6):1981-92. PubMed ID: 23378344
[TBL] [Abstract][Full Text] [Related]
10. EMT-related protein expression in polyploid giant cancer cells and their daughter cells with different passages after triptolide treatment.
Wang X; Zheng M; Fei F; Li C; Du J; Liu K; Li Y; Zhang S
Med Oncol; 2019 Aug; 36(9):82. PubMed ID: 31407170
[TBL] [Abstract][Full Text] [Related]
11. miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer.
Yu J; Xie F; Bao X; Chen W; Xu Q
Mol Cancer; 2014 May; 13():121. PubMed ID: 24885626
[TBL] [Abstract][Full Text] [Related]
12. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J
Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155
[TBL] [Abstract][Full Text] [Related]
13. Gemifloxacin inhibits migration and invasion and induces mesenchymal-epithelial transition in human breast adenocarcinoma cells.
Chen TC; Hsu YL; Tsai YC; Chang YW; Kuo PL; Chen YH
J Mol Med (Berl); 2014 Jan; 92(1):53-64. PubMed ID: 24005829
[TBL] [Abstract][Full Text] [Related]
14. Triptolide Attenuates Renal Tubular Epithelial-mesenchymal Transition Via the MiR-188-5p-mediated PI3K/AKT Pathway in Diabetic Kidney Disease.
Xue M; Cheng Y; Han F; Chang Y; Yang Y; Li X; Chen L; Lu Y; Sun B; Chen L
Int J Biol Sci; 2018; 14(11):1545-1557. PubMed ID: 30263007
[TBL] [Abstract][Full Text] [Related]
15. Triptolide inhibits CD133
Acikgoz E; Tatar C; Oktem G
J Cell Biochem; 2020 Jun; 121(5-6):3313-3324. PubMed ID: 31904143
[TBL] [Abstract][Full Text] [Related]
16. GD2 and its biosynthetic enzyme GD3 synthase promote tumorigenesis in prostate cancer by regulating cancer stem cell behavior.
Bhat AM; Mohapatra BC; Luan H; Mushtaq I; Chakraborty S; Kumar S; Wu W; Nolan B; Dutta S; Storck MD; Schott M; Meza JL; Lele SM; Lin MF; Cook LM; Corey E; Morrissey C; Coulter DW; Rowley MJ; Natarajan A; Datta K; Band V; Band H
Sci Rep; 2024 Jun; 14(1):13523. PubMed ID: 38866755
[TBL] [Abstract][Full Text] [Related]
17. Hard antler extract inhibits invasion and epithelial-mesenchymal transition of triple-negative and Her-2
Xu G; Zhao H; Xu J; Zhang Y; Qi X; Shi A
J Ethnopharmacol; 2021 Apr; 269():113705. PubMed ID: 33346025
[TBL] [Abstract][Full Text] [Related]
18. TNF differentially regulates ganglioside biosynthesis and expression in breast cancer cell lines.
Dewald JH; Cavdarli S; Steenackers A; Delannoy CP; Mortuaire M; Spriet C; Noël M; Groux-Degroote S; Delannoy P
PLoS One; 2018; 13(4):e0196369. PubMed ID: 29698439
[TBL] [Abstract][Full Text] [Related]
19. 13
Souid S; Elsayed HE; Ebrahim HY; Mohyeldin MM; Siddique AB; Karoui H; El Sayed KA; Essafi-Benkhadir K
Mol Carcinog; 2018 Nov; 57(11):1507-1524. PubMed ID: 29978911
[TBL] [Abstract][Full Text] [Related]
20. FOXF2 suppresses the FOXC2-mediated epithelial-mesenchymal transition and multidrug resistance of basal-like breast cancer.
Cai J; Tian AX; Wang QS; Kong PZ; Du X; Li XQ; Feng YM
Cancer Lett; 2015 Oct; 367(2):129-37. PubMed ID: 26210254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
